UAB Medical Genomics Lab (@UABMGL) header
UAB Medical Genomics Lab (@UABMGL) profile picture

The UAB Medical Genomics Laboratory (MGL) specializes in testing for all RASopathies including the neurofibromatoses and schwannomatosis.

Joined March 2022
Photo by UAB Medical Genomics Lab (@UABMGL)Photo by UAB Medical Genomics Lab (@UABMGL)Photo by UAB Medical Genomics Lab (@UABMGL)Photo by UAB Medical Genomics Lab (@UABMGL)Photo by UAB Medical Genomics Lab (@UABMGL)Photo by UAB Medical Genomics Lab (@UABMGL)Photo by UAB Medical Genomics Lab (@UABMGL)Photo by UAB Medical Genomics Lab (@UABMGL)Photo by UAB Medical Genomics Lab (@UABMGL)Photo by UAB Medical Genomics Lab (@UABMGL)
✨New Question✨ Breast cancer in women with NF1 are more likely to have HER2 ______?
54%Negative
46%Positive
13 votes • Final results
1
214
CORRECT ANSWER: Positive Evans DG et al. Breast cancer in neurofibromatosis 1: survival and risk of contralateral breast cancer in a five country cohort study. Genet Med. 2020;22:398–406. (PMID 31495828).
174
✨New Question✨ True or False: A patient has two orbital plexiform neurofibromas on the same side, and also has sphenoid wing dysplasia. This patient can be clinically diagnosed with NF1 based on the revised NF1 diagnostic criteria.
40%True
60%False
10 votes • Final results
1
1
CORRECT ANSWER: False. Sphenoid wing dysplasia is not a separate criterion in those with ipsilateral orbital plexiform neurofibromas.
122
NF1 is inherited in an autosomal dominant manner. Approximately __ individuals have NF1 as the result of a de novo NF1 disease-causing variant. Each child of an individual with NF1 has a __ chance of inheriting the disease-causing variant. Penetrance of NF1 is close to __.
38%30%, 50%, 80%
50%50%, 50%, 100%
0%50%, 100%, 100%
12%50%, 50%, 90%
16 votes • Final results
1
1
CORRECT ANSWER: 50%, 50%, 100%
We are thankful for all of the wonderful Genetic Counselors out there! #GCAwarenessDay
2
✨New Question✨ Did you know the UAB MGL offers genetic testing for VHL? See our website to learn more!
1
1
Answer below 👇
67%Type 1
33%Type 2
3 votes • Final results
2
CORRECT ANSWER: Type 2 Pathogenic truncating or missense variants that are predicted to grossly disrupt the folding of the VHL protein are associated with VHL type 1. Individuals with VHL type 2 commonly have a pathogenic missense variant. (ncbi.nlm.nih.gov/books/NBK14…)
✨New Question✨ Which of the following health condition is not associated with SMARCB1 gene?
35%Coffin-Siris Syndrome
18%Rhabdoid tumor predis syn
0%Schwannomatosis
47%Noonan syndrome
17 votes • Final results
1
1
✨New Question✨ Identifying the lesions that cause NF1 presents a complex challenge, which of the following is not the reason:
12%Large size of NF1 gene
12%Lack of hot spots in NF1
50%Pseudogenes of NF1
25%High GC content of NF1
8 votes • Final results
1
1
ANSWER: High GC Content of NF1 The mean GC content across all NF1 exons is 42%. Only exon 1 has high GC content which is 71%.
Calling fellow NF/SWN genetic counselors, old and new. There will be a dinner at NSGC to discuss clinical educational resources for our NF/SWN patients and would love for you to join! Please message me here for more information 😊 -Bryce Brown, MS, LCGC
✨New Question✨ If both parents have NF1, what is the chance the couple will have a child without NF1?
52%1/4
13%1/3
23%1/2
13%3/4
31 votes • Final results
2
1
ANSWER: 1/3 Homozygous NF1 is not compatible with life. If both parents have NF1, the chance of having a child with NF1 is 2/3 and a child without NF1 is 1/3.
1
1
1
Answer Below:
58%True
42%False
12 votes • Final results
True or False: The LZTR1 gene has been associated with schwannomatosis tumor predisposition and is located in a region that is deleted in the great majority (89%) of patients with 22q11.2 deletion syndrome (22q11.2DS). These patients have a higher risk of developing schwannomas.
56%True
44%False
18 votes • Final results
1
2
1
Answer: false. 22q11.2 deletion confers a reduced risk of schwannoma. PMID: 33879870